David Elkins

David Elkins is the Chief Financial Officer of Bristol Myers Squibb, a global biopharmaceutical company, where he oversees financial strategies and operations. He has been in the news for expressing concerns about the potential impact of U.S. trade policies on innovation and access to medicines for patients.